Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

proteins

  • You have access
    Expression of DNA Mismatch Repair Proteins, PD1 and PDL1 in Barrett’s Neoplasia
    JAMES J. SALLER, LINDA B. MORA, AEJAZ NASIR, ZACHARY MAYER, MOHAMMAD SHAHID and DOMENICO COPPOLA
    Cancer Genomics & Proteomics March 2022, 19 (2) 145-150; DOI: https://doi.org/10.21873/cgp.20310
  • Open Access
    Frequency of Mismatch Repair Protein Deficiency in a Puerto Rican Population with Colonic Adenoma and Adenocarcinoma
    DAYANA REVERÓN, CHRISTIAN LÓPEZ, SYLVIA GUTIÉRREZ, ZENA E. SAYEGH, TERESITA ANTONIA, JULIE DUTIL, MOKENGE MALAFA and DOMENICO COPPOLA
    Cancer Genomics & Proteomics July 2018, 15 (4) 265-271; DOI: https://doi.org/10.21873/cgp.20084
  • You have access
    Differences in mRNA and microRNA Microarray Expression Profiles in Human Colon Adenocarcinoma HT-29 Cells Treated with either Intensity-modulated Radiation Therapy (IMRT), or Conventional Radiation Therapy (RT)*
    FARID E. AHMED, PAUL W. VOS, CLARK JEFFRIES, JOHN E. WILEY, DOUGLAS A. WEIDNER, HELVECIO MOTA, CHRIS BONNERUP, CLAUDIO SIBATA and RON R. ALLISON
    Cancer Genomics & Proteomics March 2009, 6 (2) 109-127;
Cancer & Genome Proteomics

© 2026 Cancer Genomics & Proteomics

Powered by HighWire